Scilex Holding Company SCLX
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -92.56%
- 1 year
- -95.21%
Held by funds
10 US ETFs and mutual funds hold SCLX · largest positions
Ownership
- Institutions 14.5%
- Insiders 26.3%
- Public and other holders 59.2%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| State Street Corporation | 3.90% | 7,484,310 | 3.42M | Sep 29, 2024 |
| Blackrock Inc. | 3.50% | 6,707,701 | 3.06M | Sep 29, 2024 |
| Vanguard Group Inc | 3.15% | 6,038,211 | 2.76M | Sep 29, 2024 |
| Armistice Capital, LLC | 1.83% | 3,510,000 | 1.60M | Sep 29, 2024 |
| Millennium Management Llc | 0.76% | 1,461,034 | 667.40K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.68% | 1,295,330 | 591.71K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.10% | 5,938,524 | 2.71M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.94% | 3,712,119 | 1.70M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.15% | 2,213,274 | 1.01M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 0.75% | 1,430,471 | 653.44K | Oct 30, 2024 |
| Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 0.32% | 620,131 | 283.27K | Oct 30, 2024 |
| iShares Russell 2000 Value ETF | 0.30% | 576,358 | 263.28K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs SCLX, and what each was last paid
Henry H. Ji, Chief Executive Officer, President & Executive ChairmanAverage age 62
| Name | Title | Pay | Age |
|---|---|---|---|
| Henry H. Ji | Chief Executive Officer, President & Executive Chairman | $1.58M | 62 |
| Stephen Ma | Senior Vice President, Chief Financial Officer, Chief Operating Officer, Corporate Secretary & Director | $719K | 53 |
| Dmitri V. Lissin | Senior Vice President of Clinical Development and Medical Affairs & Interim Chief Medical Officer | $529K | 67 |
| Suresh K. Khemani | Senior Vice President, Chief Commercial Officer & GM of Scilex Pharma | $457K | 66 |
| Suketu D. Desai | Interim Chief Technical Officer & Senior Vice President | — | 61 |
| Gigi DeGuzman | Vice President & Chief People Officer | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHUN JAY | Director | Purchase | Oct 17, 2024 | 112,511 |
| FOLLOWWILL DORMAN | Director | Purchase | Oct 17, 2024 | 2,300 |
| JI HENRY H | Officer and Director | Purchase | Oct 30, 2024 | 680,884 |
| LEMUS DAVID | Director | Purchase | Oct 16, 2024 | 2,000 |
| MA STEPHEN HOI | Chief Financial Officer | Purchase | Oct 15, 2024 | 22,840 |
| SHAH JAISIM | Chief Executive Officer | Purchase | Dec 17, 2024 | 295,215 |
